Page 9 - News Report - די צייטונג
P. 9
NEWS REPORT FRIDA • • • • ° ±¿´·¸¸Å ¸²
FRIDAY, OCTOBER 6-8, '21Y, OCTOBER 6-8, '21
°" §ÃÈÉ ,¶¿ ' §Ã ,±¯·¸¸ÇÃ" §ÃÈÉ ,¶¿ ' §Ã ,±¯·¸¸ÇÃ
COVID- 1 9 COMMUNITY HEALTH UPDATE - SEPTEMBER 2, 2021
URGENT MESSAGE FROM YOUR COMMUNITY PHYSICIANS:
URGENT MESSAGE FROM YOUR COMMUNITY PHYSICIANS:
The more contagious COVID- 19 Delta variant is currently circulating
throughout the world with a rise in cases and hospitalizations
throughout the USA. Exposure to COVID- 19 is imminent.
COVID-19 vaccination in all eligible agegroups
COVID-19 vaccination in all eligible age groups
remains the SAFEST and most EFFECTIVE
remains the SAFEST and most EFFECTIVE
method to reduce your risk of becoming
method to reduce your risk of becoming
infected or severely ill from SARS-CoV2.
infeff cted or severely ill frff om SARS-CoV2.
We ask you to consider these important points when making your decision regarding vaccination:
5 BILLION DOSES of the COVID-19 vaccines have been administered throughout the world. The mRNA
technology has been studied for over two decades and the Moderna and Pfizer vaccines have been studied
in humans for over a year. The Pfizer mRNA vaccine has received full FDA licensure for ages 16
years and up.
The majority of current COVID-19 HOSPITALIZATIONS, ICU cases and DEATHS are '& occurring in
UNVACCINATED patients. Although rising cases of the Delta variant has caused breakthrough infections
in vaccinated individuals, the course of COVID-19 is generally milder in those who are vaccinated.
Ages 12 to 16 years old are eligible for COVID-19 vaccines. While severe COVID-19 disease is rare in
children, adverse events including myocarditis are much more likely to occur from infection
itself than from vaccination.
Very few risks have been linked to the various COVID-19 vaccines (collectively including anaphylaxis,
blood clots, Guillain-Barré, myocarditis). They are exceedingly rare and often treatable. In contrast, many of
these same adverse events as well as severe disease, long COVID, and death are much more likely to occur
from COVID-19 infection itself.
The vaccine does not cause infertility or harm pregnancy. In contrast, pregnant women and unborn
babies remain at increased risk of complications from COVID-19 infection.
Third dose vaccines are currently recommended for the immunocompromised and other high-risk
individuals and may soon be recommended for the general population.
IN PEOPLE WITH A HISTORY OF COVID-19 INFECTION OR ANTIBODIES, THE
COVID-19 VACCINES SAFELY PROVIDE A BENEFICIAL BOOST IN IMMUNITY,
REDUCING THE LIKELIHOOD OF REINFECTION AND SEVERE DISEASE.
We are "( for a ' "& to all &' and for a decrease in suffering from this " .
FRIDAY, OCTOBER 6-8, '21Y, OCTOBER 6-8, '21
°" §ÃÈÉ ,¶¿ ' §Ã ,±¯·¸¸ÇÃ" §ÃÈÉ ,¶¿ ' §Ã ,±¯·¸¸ÇÃ
COVID- 1 9 COMMUNITY HEALTH UPDATE - SEPTEMBER 2, 2021
URGENT MESSAGE FROM YOUR COMMUNITY PHYSICIANS:
URGENT MESSAGE FROM YOUR COMMUNITY PHYSICIANS:
The more contagious COVID- 19 Delta variant is currently circulating
throughout the world with a rise in cases and hospitalizations
throughout the USA. Exposure to COVID- 19 is imminent.
COVID-19 vaccination in all eligible agegroups
COVID-19 vaccination in all eligible age groups
remains the SAFEST and most EFFECTIVE
remains the SAFEST and most EFFECTIVE
method to reduce your risk of becoming
method to reduce your risk of becoming
infected or severely ill from SARS-CoV2.
infeff cted or severely ill frff om SARS-CoV2.
We ask you to consider these important points when making your decision regarding vaccination:
5 BILLION DOSES of the COVID-19 vaccines have been administered throughout the world. The mRNA
technology has been studied for over two decades and the Moderna and Pfizer vaccines have been studied
in humans for over a year. The Pfizer mRNA vaccine has received full FDA licensure for ages 16
years and up.
The majority of current COVID-19 HOSPITALIZATIONS, ICU cases and DEATHS are '& occurring in
UNVACCINATED patients. Although rising cases of the Delta variant has caused breakthrough infections
in vaccinated individuals, the course of COVID-19 is generally milder in those who are vaccinated.
Ages 12 to 16 years old are eligible for COVID-19 vaccines. While severe COVID-19 disease is rare in
children, adverse events including myocarditis are much more likely to occur from infection
itself than from vaccination.
Very few risks have been linked to the various COVID-19 vaccines (collectively including anaphylaxis,
blood clots, Guillain-Barré, myocarditis). They are exceedingly rare and often treatable. In contrast, many of
these same adverse events as well as severe disease, long COVID, and death are much more likely to occur
from COVID-19 infection itself.
The vaccine does not cause infertility or harm pregnancy. In contrast, pregnant women and unborn
babies remain at increased risk of complications from COVID-19 infection.
Third dose vaccines are currently recommended for the immunocompromised and other high-risk
individuals and may soon be recommended for the general population.
IN PEOPLE WITH A HISTORY OF COVID-19 INFECTION OR ANTIBODIES, THE
COVID-19 VACCINES SAFELY PROVIDE A BENEFICIAL BOOST IN IMMUNITY,
REDUCING THE LIKELIHOOD OF REINFECTION AND SEVERE DISEASE.
We are "( for a ' "& to all &' and for a decrease in suffering from this " .
